Modeling Hepatotropic Viral Infections: Cells vs. Animals
The lack of an appropriate platform for a better understanding of the molecular basis of hepatitis viruses and the absence of reliable models to identify novel therapeutic agents for a targeted treatment are the two major obstacles for launching efficient clinical protocols in different types of vir...
Main Authors: | Niloofar Khoshdel-Rad, Ensieh Zahmatkesh, Polina Bikmulina, Maria Peshkova, Nastasia Kosheleva, Evgeny A. Bezrukov, Roman B. Sukhanov, Anna Solovieva, Anastasia Shpichka, Peter Timashev, Massoud Vosough |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/7/1726 |
Similar Items
-
Hepatotropic medicines: current status
by: Sergey Vladimirovich Okovityy, et al.
Published: (2012-02-01) -
Emerging Hepatotropic Viruses in Cats: A Brief Review
by: Paolo Capozza, et al.
Published: (2021-06-01) -
Hepatotropic Therapy in Treatment of Liver Injury
by: D. S. Sukhanov, et al.
Published: (2020-05-01) -
Efficacy of the infusion hepatotropic drug remaxol in the pathogenetic therapy for cirrhotic stage chronic viral hepatitides
by: V V Stelmakh, et al.
Published: (2015-08-01) -
Studying T Cell Responses to Hepatotropic Viruses in the Liver Microenvironment
by: Jarrett Lopez-Scarim, et al.
Published: (2023-03-01)